AVCA Questions Legality of New Zealand Tobacco Control Amendments

Dec.16.2022
AVCA Questions Legality of New Zealand Tobacco Control Amendments
New Zealand's proposed tobacco regulations may unintentionally promote a black market and make smoking more attractive to youths.

Earlier this year, the New Zealand Parliament's health select committee reviewed proposed amendments related to smoke-free environments and tobacco control products submitted by members of the public. The Aotearoa Vapers Community Advocacy (AVCA) has claimed that one aspect of the proposed legislation may even be illegal.


The Smoke-free Environments and Regulated Products (Smoking Tobacco) Amendment Bill in New Zealand has limited the number of retailers who can sell tobacco products and banned sales to anyone born after 2009, in an effort to reduce the appeal and addiction of tobacco products.


The tobacco ban passed down through generations may potentially fuel the already existing black market, and inadvertently make smoking more attractive to young people.


Last year, AVCA was one of the local groups publicly calling for stronger enforcement. "Retailers have had plenty of time to distinguish right from wrong. I respect the government's initial focus on providing new legal education to retailers, but now it is time to start enforcement," they stated.


The AVCA has tentatively agreed to support the "smoke-free generation" initiative but expresses concern about potential overreach. The organization reminds us that New Zealand's current youth smoking rates are already well below the 2025 goal of 5% or less of regular smokers. AVCA co-founder Nancy Loucas made this statement.


At the same time, she emphasized the need for members of the select committee to study whether a ban on intergenerational tobacco would fuel existing black markets and inadvertently make smoking more attractive to typically rebellious youth.


Furthermore, when implemented on a large scale, a ban on smoking across generations may even be illegal. "All adults have the right to make wise choices. The government needs to be sure that this will be legally viable before implementing it. I am concerned that banning a consumer product when a group of people reach adulthood, while allowing access to other adult products such as alcohol, may not be fair," said Lucas.


Low-nicotine cigarettes also pose problems.


The AVCA also stated that the proposal to reduce nicotine levels in cigarettes by forcing the sale of very low nicotine cigarettes (VLNC) could pose problems. There is insufficient research to suggest that VLNCs help people quit smoking. In fact, data from countries that have set nicotine limits indicate that they may be harmful.


The government's strong stance on tobacco is good news, but it needs to ensure that generational bans and measures like VLNC are legally implemented while being closely watched worldwide. New Zealand is leading the way in promoting electronic cigarettes as an effective tool for quitting smoking. Now, it has the opportunity to showcase best practices in eliminating deadly smoking," added Lucas.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report|U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window
Special Report|U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window
Vapesourcing has listed RELX Creator Pro 15K as “Coming Soon” with U.S. warehouse shipping options; while the page does not show that RELX has entered the U.S. market through official channels or that the product has received FDA authorization, the listing suggests that Chinese brand-led ENDS products are becoming a new point of observation as the U.S. market reassesses regulatory risk following the FDA’s updated enforcement-priority policy.
Industry Insight
Jun.11
UK Vaping Products Duty to Raise £565 Million by 2030/31
UK Vaping Products Duty to Raise £565 Million by 2030/31
The UK will introduce Vaping Products Duty on all vaping liquids from October 1, 2026, with government revenue forecast to rise from £135 million in 2026/27 to £565 million by 2030/31.
Jun.18
Data|China’s January-May 2026 Device Exports Rise 13% While Nicotine Product Exports Decline 6.9%
Data|China’s January-May 2026 Device Exports Rise 13% While Nicotine Product Exports Decline 6.9%
According to China Customs export data analyzed by 2Firsts, China’s vape export mix continued to evolve during January-May 2026. Exports of electronic vaporisation devices (HS 85434000) increased 13.00% year on year, supported by growth in both shipment volume and average export prices. Meanwhile, exports of nicotine-containing non-combustible products (HS 24041200) declined 6.89%, with lower shipment volumes partly offset by higher average export prices.
Special Report
Jun.30
Product|PMI Expands High-Strength Nicotine Pouch Portfolio With Zyn 16.5mg
Product|PMI Expands High-Strength Nicotine Pouch Portfolio With Zyn 16.5mg
According to Better Retailing, Philip Morris International (PMI) has launched Zyn Menthol Ice 16.5mg in the UK, marking the highest-strength nicotine pouch in the Zyn range to date. The eucalyptus- and menthol-flavored product is now available through PMI Open and will begin rolling out to wholesale channels from the end of May.
PMI
May.28
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01
2Firsts Hosts U.S. Compliance Briefing on Building PMTA Support Capabilities Across the Nicotine Supply Chain
2Firsts Hosts U.S. Compliance Briefing on Building PMTA Support Capabilities Across the Nicotine Supply Chain
2Firsts held a U.S. compliance briefing in Shenzhen to help vaping, heated tobacco and nicotine pouch supply chain companies strengthen PMTA support capabilities. The event focused on supplier documentation, quality systems, traceability, TPMF/TPMP pathways, age verification and customer audit readiness as U.S. compliance expectations increasingly extend deeper into the nicotine supply chain.
Events
Jun.12